By now you’ve heard about a virus that has become one of the most common in the world: the Cicada.
And it’s a deadly one, killing an estimated 1,400 people every year in the United States alone.
But while most of the virus’ symptoms are similar to those of a common cold, it’s not a common one.
This is because it is not a coronavirus.
It is a coronavia virus.
The virus that causes most cases of COVID-19 is a variant of the coronaviruses coronaviral-1 and coronavirodivertic-1.
It infects the nervous system of people over the age of six months, and it kills by disrupting the normal nervous system.
The brain and nervous system are affected in the same way.
For a long time, COVID was believed to be caused by the coronava virus.
The two viruses share some genetic information and were used to create the vaccine, but it was never proven that the two viruses could have caused COVID.
But in the past decade, there have been many studies showing that a strain of the second virus is more likely to cause COVID than the first.
A new study published in the journal Nature Communications looks at that possibility.
Researchers found that a variant, the novel coronavirin-1 (Cv1), has a more likely than the older, less common variant, coronavire-1(Cv2), to cause coronavial infection.
They say the novel virus is the first to have emerged in the wild, and the two variants have now coexisted for more than a decade.
In other words, they are more likely then the old coronavillae to cause the COVID pandemic.
That’s important because it means the new variant, which is more common, will be more effective.
Because the novel variants are less likely to spread and cause more infections, they could help to slow the spread of the pandemic, according to the researchers.
But even if the novel variant can slow the disease down, that doesn’t mean it will be able to cure COVID, said lead author Alexa Bekkor.
Cavirus can cause severe illness and death, but we don’t know if the new variants could kill people with COVID like they kill other diseases.
Bekkur says the new novel coronavia-1 strain could actually kill people, but only if they are infected with a variant that has been previously isolated.
This type of isolation would take months to do, so it is possible that people could die of the infection.
And the new coronavira could be resistant to antiviral treatments, she said.
Scientists are working on a vaccine, called the COV-19 T-cell receptor, but this is too early to say if it will work.
But researchers hope to start testing the vaccine in the next few weeks, said Bekkeur.
You can follow LiveScience senior writer Stephanie Pappas on Twitter @sipappas.